HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fibrin cross-linking in congenital factor XIII deficiency.

Abstract
Homozygous patients with factor XIII deficiency are devoid of immunologically identifiable A protein, the active enzymatic component. Quantitative studies of transamidase activity of the factor are available in only a few cases, and the fibrin cross-linking pattern is not well known. The present paper deals with the quantitative estimation of factor XIII transamidase activity (dansylcadaverine system), factor XIII molecular subunits, and the corresponding fibrin cross-linking pattern in seven homozygous patients with factor XIII deficiency. The results indicate that transamidase activity was present in all patients, and the range was 0.5-1.7%. The pattern of fibrin stabiisation showed an absence of cross-linking in two patients, the presence of gamma-gamma-dimers (traces) in four, and gamma-gamma-dimers plus incomplete alpha-polymers (traces) in one patient. In conclusion, the homozygous patients reported here were not completely devoid of functioning factor XIII.
AuthorsF Rodeghiero, T Barbui
JournalJournal of clinical pathology (J Clin Pathol) Vol. 33 Issue 5 Pg. 434-7 (May 1980) ISSN: 0021-9746 [Print] England
PMID7400341 (Publication Type: Journal Article)
Chemical References
  • Fibrin
  • Factor XIII
  • Thrombin
Topics
  • Electrophoresis, Polyacrylamide Gel
  • Enzyme Activation
  • Factor XIII (analysis, metabolism)
  • Factor XIII Deficiency (blood)
  • Fibrin
  • Humans
  • Protein Binding
  • Thrombin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: